Position in DXCM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$434,542
+$54,602 QoQ
Shares Held
6,452
+6.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#592
of 966 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Callan Family Office, LLC holds $37,007,846 across 17 Medical Devices names. DXCM ranks #11 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
94,188 | $8,546,619 | |
| 2 | ZBH |
Zimmer Biomet Holdings, Inc.
|
66,996 | $5,767,685 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
76,134 | $4,873,337 | |
| 4 | PHG |
Koninklijke Philips NV
|
139,095 | $3,781,993 | |
| 5 | SYK |
Stryker Corp
|
10,922 | $3,438,682 | |
| 6 | MDT |
Medtronic plc
|
34,958 | $2,734,764 | |
| 7 | BSX |
Boston Scientific Corp
|
52,745 | $2,251,156 | |
| 8 | EW |
Edwards Lifesciences Corp
|
24,836 | $2,246,664 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $434,542 | 6,452 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $379,940 | 6,050 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $898,716 | 13,541 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,455,415 | 21,629 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,080,295 | 23,832 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $504,594 | 7,389 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $238,053 | 3,061 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||